NewBorn Screening Market by Test Type, Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit - Global Forecast to 2019

LONDON, July 21, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

NewBorn Screening Market by Test Type, Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit – Global Forecast to 2019

https://www.reportbuyer.com/product/2238103/NewBorn-Screening-Market-by-Test-Type-Technology-Tandem-Mass-Spectrometry-Immunoassay-Enzyme-Assay-Electrophoresis-Pulse-Oximeter-Instrument-Accessories-Reagent--Assay-Kit-–-Global-Forecast-to-2019.html

The global newborn screening market is categorized on the basis of test type, technology, product, and geography. The mass spectrometry market is expected to register the highest growth rate in the newborn screening market by technology, during the forecast period. This high growth is attributed to various nations opting for expanded newborn screening. Tandem mass spectrometry is a fundamental instrument used for expanded newborn screening. Furthermore, various conferences and symposiums are being conducted to spread awareness for the use of such technologies. For instance, in May 2013, the Joint Meeting of the Newborn Screening and Genetic Testing Symposium was organized in Atlanta. The symposium was aimed to discuss national and international newborn screening, genetic testing, and policy issues.

Major factors contributing to growth of newborn screening include government support in the form funding and rising awareness regarding new technologies. Furthermore, owing to continuous advancements in technology, new devices are being launched in the market which is another major factor providing impetus for growth of the market. The emerging Asian region and advent of next-generation sequencing technology are likely to provide opportunities for newborn screening market to grow. However, factors such as lack of trained professional infrastructure and socio-economical barriers may restrain the growth of this market.

The Asian region is expected to serve as a new revenue pocket for the newborn screening market in the coming five years.

Apart from the comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise the basic views on the key players in the newborn screening market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecasts of future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on product portfolios of top players in the human identification market. The report analyzes the newborn screening market by test type, technology, product, and geography
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the newborn screening market
• Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of leading players in the newborn screening market
• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various newborn screening products across geographies
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the newborn screening market

1 INTRODUCTION 19

1.1 OBJECTIVES OF THE STUDY 20
1.1.1 KEY INSIGHTS FROM THE REPORT 20
1.2 SCOPE OF THE REPORT 22
1.2.1 MARKETS COVERED 22
1.2.2 LIMITATIONS OF THE STUDY 23
1.3 STAKEHOLDERS 24
1.4 RESEARCH METHODOLOGY 24
1.4.1 MARKET SIZE ESTIMATION 26
1.4.2 MARKET CRACKDOWN & DATA TRIANGULATION 28
1.4.3 MARKET SHARE ESTIMATION 29
1.4.4 KEY DATA FROM PRIMARY SOURCES 30
1.4.5 KEY DATA FROM SECONDARY SOURCES 31
1.4.6 ASSUMPTIONS 31

2 EXECUTIVE SUMMARY 32

3 PREMIUM INSIGHTS 36

3.1 TECHNOLOGY TRENDS 37
3.2 WINNING IMPERATIVE 38
3.2.1 INVESTMENTS IN R&D ACTIVITIES FOR PRODUCT INNOVATION 38
3.3 PORTER'S FIVE FORCES ANALYSIS 39
3.3.1 THREAT OF NEW ENTRANTS 39
3.3.2 BARGAINING POWER OF SUPPLIERS 40
3.3.3 BARGAINING POWER OF BUYERS 40
3.3.4 RIVALRY AMONGST EXISTING PLAYERS 40
3.3.5 THREAT OF SUBSITUTES 41
3.4 REGULATORY ENVIRONMENT 42
3.5 REIMBURSEMENT SCENARIO 43
3.6 TECHNOLOGY LIFE CYCLE 44
3.7 STRATEGIC BENCHMARKING 46

4 MARKET OVERVIEW 47

4.1 INTRODUCTION 48
4.1.1 COMMON INDICATIONS IN NEWBORN SCREENING 48
4.1.1.1 Phenylketonuria (PKU) 48
4.1.1.2 Congenital hypothyroidism (CH) 49
4.1.1.3 Galactosemia 49
4.1.1.4 Biotinidase deficiency 49
4.1.1.5 Congenital adrenal hyperplasia (CAH) 50
4.1.1.6 Cystic fibrosis (CF) 50
4.1.1.7 Sickle cell disease 50
4.1.1.8 Maple syrup urine disease 51
4.1.1.9 Tryosinemia 51
4.1.1.10 Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency 52
4.1.1.11 Congenital toxoplasmosis 52
4.1.1.12 Newborn hearing loss 52
4.1.1.13 Critical congenital heart diseases 52
4.1.2 NEWBORN SCREENING CONFIRMATORY TEST 53
4.2 MARKET SEGMENTATION 57
4.3 MARKET DYNAMICS 59
4.3.1 DRIVERS 60
4.3.1.1 Benefits related to newborn screening to propel the growth of the market 60
4.3.1.2 Legislations and mandates demand the implementation of newborn screening programs 60
4.3.1.3 Government support, an impetus for the newborn screening market 61
4.3.1.4 Rising awareness to trigger the growth of the market 61
4.3.1.5 Technological innovations to propel the growth of the market 62
4.3.1.6 Expanding panel of newborn diseases to bolster the growth of the market 63
4.3.1.7 Rising incidences of critical congenital heart defects (CCHD) to propel the CCHD screening market 63
4.3.2 RESTRAINTS 64
4.3.2.1 Lack of professional infrastructure may hinder the growth of the market 64
4.3.2.2 Socio-economic barriers are likely to restrain the growth of the market 64
4.3.3 OPPORTUNITIES 64
4.3.3.1 Asian region presents significant growth opportunities 64
4.3.3.2 Screening of genetic disorders 65
4.3.3.3 Next-generation sequencing(NGS), an upcoming technology in the newborn screening market 65
4.3.3.4 Digital microfluidics, a new opportunity area for the newborn screening market 66
4.3.4 CHALLENGES 66
4.3.4.1 High cost of automation 66
4.3.4.2 Survival of small players and new entrants 67
4.3.4.3 Lack of uniformity of newborn screening policies and procedures across the globe 67
4.4 MARKET SHARE ANALYSIS 68
4.4.1 GLOBAL NEWBORN SCREENING DRIED BLOOD SPOT TEST MARKET 68
4.4.1.1 North America: Newborn Screening Dried Blood Spot Test Market 72
4.4.1.2 Europe: Newborn Screening Dried Blood Spot Test Market 73
4.4.1.3 Asia: Newborn Screening Dried Blood Spot Test Market 74
4.4.1.4 RoW: Newborn Screening Dried Blood Spot Test Market 75
4.4.2 NEWBORN SCREENING MARKET FOR CRITICAL CONGENITAL HEART DISEASES 76
4.4.3 NEWBORN HEARING SCREENING MARKET 77

5 NEWBORN SCREENING MARKET, BY TEST TYPE 78

5.1 INTRODUCTION 79
5.2 DRY BLOOD SPOT TEST 83
5.3 HEARING SCREEN TEST 85
5.4 CRITICAL CONGENITAL HEART DISEASES (CCHD) TEST 87

6 NEWBORN SCREENING MARKET, BY TECHNOLOGY 89

6.1 INTRODUCTION 90
6.2 TANDEM MASS SPECTROMETRY (TMS) 93
6.3 ELECTROPHORESIS 95
6.4 IMMUNOASSAYS AND ENZYMATIC ASSAYS 97
6.5 DNA-BASED ASSAYS 99
6.6 HEARING SCREEN TECHNOLOGY 101
6.7 PULSE OXIMETRY SCREENING TECHNOLOGY 103

7 NEWBORN SCREENING MARKET, BY PRODUCT TYPE 105

7.1 INTRODUCTION 106
7.2 INSTRUMENTS 109
7.2.1 INTRODUCTION 109
7.2.2 NEWBORN DISORDER SCREENING INSTRUMENTS 111
7.2.3 NEWBORN HEARING SCREENING INSTRUMENTS 113
7.2.3.1 Hearing screening devices 116
7.2.3.2 Hearing screening accessories 117
7.2.4 PULSE OXIMETERS 119
7.3 REAGENTS AND ASSAY KITS 121

8 NEWBORN SCREENING MARKET, BY GEOGRAPHY 123

8.1 INTRODUCTION 124
8.2 NORTH AMERICA 128
8.2.1 NEED FOR REDUCING HEALTHCARE COSTS, A MAJOR DRIVER FOR THE U.S. NEWBORN SCREENING MARKET 128
8.2.2 GOVERNMENT SUPPORT, AN IMPETUS FOR THE MARKET 128
8.2.3 NEWBORN SCREENING PROGRAM IN CANADA 137
8.2.4 NEWBORN HEARING SCREENING PROGRAM IN CANADA 144
8.2.5 ISSUES OVER PRIVACY RIGHTS OF FAMILIES MAY HINDER THE GROWTH OF THE CANADIAN MARKET 144
8.2.6 SYMPOSIUMS AND MEETINGS TO TRIGGER THE GROWTH OF THE NEWBORN SCREENING MARKET 144
8.3 SOUTH AMERICA 150
8.3.1 GROWTH IN THE SOUTH AMERICAN MARKET TO BE HINGED AT BRAZIL 150
8.3.2 RESEARCH STUDIES TO ENHANCE THE NEWBORN SCREENING PROGRAM 151
8.3.3 LACK OF TRAINED PROFESSIONALS TO HINDER THE GROWTH OF THE NEWBORN HEARING SCREENING MARKET 151
8.4 EUROPE 157
8.4.1 EUROPEAN UNION INITIATIVES TO PROPEL THE GROWTH OF THE MARKET 157
8.4.2 NEWBORN SCREENING PROGRAM IN VARIOUS EUROPEAN COUNTRIES 158
8.4.3 CONFERENCES TO RAISE AWARENESS REGARDING CCHD SCREENING 159
8.4.4 NEWBORN HEARING SCREENING PROGRAM IN EUROPE 159
8.4.5 GOVERNMENT INITIATIVES TO BOLSTER THE GROWTH OF THE EUROPEAN MARKET 160
8.4.6 LAUNCH OF NEW & ADVANCED PRODUCTS TO PROPEL THE GROWTH OF THE EUROPEAN MARKET 160
8.4.7 CONFERENCES TO BOOST THE GROWTH OF THE NEWBORN SCREENING MARKET 160
8.5 ASIA 165
8.5.1 GOVERNMENT INITIATIVES TO DRIVE THE GROWTH OF THE ASIAN MARKET 170
8.5.1.1 Japanese government initiatives 170
8.5.1.2 Indian government initiatives 170
8.5.1.3 Philippines government initiatives 171
8.5.2 COLLABORATION AMONGST LEADING PLAYERS AND GOVERNMENT TO BOOST THE CHINESE MARKET 171
8.6 ROW 173
8.6.1 NEWBORN SCREENING PROGRAM IN AUSTRALIA AND NEW ZEALAND 173
8.6.2 NEWBORN SCREENING PROGRAM IN SOUTH AFRICA 173
8.6.3 AFRICAN & MIDDLE EASTERN COUNTRIES TAKING INITIATIVES TO LAUNCH AND IMPROVE THEIR NEWBORN SCREENING PROGRAMS 173
8.6.4 SUPPORT BY FOREIGN COUNTRIES TO BOOST THE ROW MARKET 174

9 COMPETITIVE LANDSCAPE 179

9.1 INTRODUCTION 179
9.2 PARTNERSHIPS, AGREEMENTS, COLLABORATIONS, AND CONTRACTS 180
9.3 NEW PRODUCT LAUNCHES 185
9.4 EXPANSIONS 188
9.5 ACQUISITIONS 191
9.6 APPROVALS 193

10 COMPANY PROFILES 194 (Overview, Financials, Products & Services, Strategy, & Developments)*

10.1 AB SCIEX LLC (A SUBSIDIARY OF DANAHER CORPORATION) 194
10.2 PERKINELMER, INC. 202
10.3 WATERS CORPORATION 208
10.4 NATUS MEDICAL INCORPORATED 213
10.5 MASIMO CORPORATION 217
10.6 AGILENT TECHNOLOGIES INC. 224
10.7 BIO-RAD LABORATORIES, INC. 229
10.8 COVIDIEN PLC 232
10.9 GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY) 236
10.10 TRIVITRON HEALTHCARE 239
*Details on Products & Services, Strategy, & Developments might not be captured in case of unlisted companies.

LIST OF TABLES

TABLE 1 SCOPE: NEWBORN SCREENING MARKET 23
TABLE 2 GLOBAL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE,
2012–2019 ($MILLION) 33
TABLE 3 GLOBAL NEWBORN SCREENING MARKET SIZE, BY GEOGRAPHY,
2012–2019 ($MILLION) 34
TABLE 4 NEWBORN SCREENING CONFIRMATORY TESTS AND TECHNOLOGIES 55
TABLE 5 NORTH AMERICA: MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2013 72
TABLE 6 EUROPE: MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2013 73
TABLE 7 ASIA: MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2013 74
TABLE 8 ROW: MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2013 75
TABLE 9 GLOBAL NEWBORN CRITICAL CONGENITAL HEART DISEASE SCREENING MARKET, BY RANKING 76
TABLE 10 GLOBAL NEWBORN HEARING SCREENING MARKET, BY KEY PLAYER, 2013 77
TABLE 11 GLOBAL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE,
2012–2019 ($MILLION) 81
TABLE 12 NEWBORN SCREENING TEST TYPE MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION) 82
TABLE 13 DRY BLOOD SPOT TEST MARKET SIZE, BY GEOGRAPHY,
2012–2019 ($MILLION) 84
TABLE 14 HEARING SCREEN TEST MARKET SIZE, BY GEOGRAPHY,
2012–2019 ($MILLION) 86
TABLE 15 CRITICAL CONGENITAL HEART DISEASES (CCHD) TEST MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION) 88
TABLE 16 GLOBAL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY,
2012–2019 ($MILLION) 91
TABLE 17 NEWBORN SCREENING TECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION) 92
TABLE 18 TANDEM MASS SPECTROMETRY MARKET SIZE, BY GEOGRAPHY,
2012–2019 ($MILLION) 94
TABLE 19 ELECTROPHORESIS MARKET SIZE, BY GEOGRAPHY,
2012–2019 ($MILLION) 96
TABLE 20 IMMUNOASSAY AND ENZYMATIC ASSAYS MARKET SIZE,
BY GEOGRAPHY, 2012–2019 ($MILLION) 98
TABLE 21 DNA-BASED ASSAY MARKET SIZE, BY GEOGRAPHY,
2012–2019 ($MILLION) 100
TABLE 22 HEARING SCREEN TECHNOLOGY MARKET SIZE, BY GEOGRAPHY,
2012–2019 ($MILLION) 102
TABLE 23 PULSE OXIMETRY SCREENING TECHNOLOGY MARKET SIZE,
BY GEOGRAPHY, 2012–2019 ($MILLION) 104
TABLE 24 GLOBAL NEWBORN SCREENING MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 107
TABLE 25 NEWBORN SCREENING PRODUCTS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION) 108
TABLE 26 NEWBORN SCREENING INSTRUMENTS MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 109
TABLE 27 NEWBORN SCREENING INSTRUMENTS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION) 110
TABLE 28 NEWBORN DISORDER SCREENING INSTRUMENTS MARKET SIZE,
BY GEOGRAPHY, 2012–2019 ($MILLION) 113
TABLE 29 NEWBORN HEARING SCREENING INSTRUMENTS MARKET SIZE,
BY PRODUCT TYPE, 2012–2019 ($MILLION) 114
TABLE 30 NEWBORN HEARING SCREENING INSTRUMENTS MARKET SIZE,
BY GEOGRAPHY, 2012–2019 ($MILLION) 115
TABLE 31 HEARING SCREENING DEVICES MARKET SIZE, BY GEOGRAPHY,
2012–2019 ($MILLION) 117
TABLE 32 HEARING SCREENING ACCESSORIES MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION) 118
TABLE 33 NEWBORN PULSE OXIMETERS MARKET SIZE, BY GEOGRAPHY,
2012–2019 ($MILLION) 120
TABLE 34 REAGENTS AND ASSAY KITS MARKET SIZE, BY GEOGRAPHY,
2012–2019 ($MILLION) 122
TABLE 35 GLOBAL NEWBORN SCREENING MARKET SIZE, BY GEOGRAPHY,
2012–2019 ($MILLION) 127
TABLE 36 U.S.: NEWBORN DISORDER SCREENING STATUS 131
TABLE 37 U.S.: CRITICAL CONGENITAL HEART DISEASES (CCHD) SCREENING IMPLEMENTATION 134
TABLE 38 CANADA: NEWBORN DISORDER SCREENING STATUS 137
TABLE 39 NORTH AMERICA: NEWBORN SCREENING MARKET SIZE,
BY TECHNOLOGY, 2012–2019 ($MILLION) 145
TABLE 40 NORTH AMERICA: NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2012–2019 ($MILLION) 146
TABLE 41 NORTH AMERICA: NEWBORN SCREENING MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 147
TABLE 42 NORTH AMERICA: NEWBORN SCREENING INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 148
TABLE 43 NORTH AMERICA: NEWBORN HEARING SCREENING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 149
TABLE 44 SOUTH AMERICA: NEWBORN SCREENING MARKET SIZE,
BY TECHNOLOGY, 2012–2019 ($MILLION) 152
TABLE 45 SOUTH AMERICA: NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2012–2019 ($MILLION) 153
TABLE 46 SOUTH AMERICA: NEWBORN SCREENING MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 154
TABLE 47 SOUTH AMERICA: NEWBORN SCREENING INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 155
TABLE 48 SOUTH AMERICA: NEWBORN HEARING SCREENING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 156
TABLE 49 EUROPE: NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 161
TABLE 50 EUROPE: NEWBORN SCREENING MARKET SIZE, BY TEST TYPE,
2012–2019 ($MILLION) 162
TABLE 51 EUROPE: NEWBORN SCREENING MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 162
TABLE 52 EUROPE: NEWBORN SCREENING INSTRUMENTS MARKET SIZE,
BY TYPE, 2012–2019 ($MILLION) 163
TABLE 53 EUROPE: NEWBORN HEARING SCREENING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 164
TABLE 55 ASIA: NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY,
2012–2019 ($MILLION) 165
TABLE 56 ASIA: NEWBORN SCREENING MARKET SIZE, BY TEST TYPE,
2012–2019 ($MILLION) 166
TABLE 57 ASIA: NEWBORN SCREENING MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 167
TABLE 58 ASIA: NEWBORN SCREENING INSTRUMENTS MARKET SIZE,
BY TYPE, 2012–2019 ($MILLION) 168
TABLE 59 ASIA: NEWBORN HEARING SCREENING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 169
TABLE 60 NEWBORN HEARING SCREENING PROGRAM 172
TABLE 61 ROW: NEWBORN SCREENING MARKET SIZE, BY TECHNOLGY,
2012–2019 ($MILLION) 175
TABLE 62 ROW: NEWBORN SCREENING MARKET SIZE, BY TEST TYPE,
2012–2019 ($MILLION) 176
TABLE 63 ROW: NEWBORN SCREENING MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 176
TABLE 64 ROW: NEWBORN SCREENING INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 177
TABLE 65 ROW: NEWBORN HEARING SCREENING INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 178
TABLE 66 PARTNERSHIPS, AGREEMENTS, COLLABORATIONS, AND CONTRACTS, 2011–2014 180
TABLE 67 NEW PRODUCT LAUNCHES, 2011–2014 185
TABLE 68 EXPANSIONS, 2011–2014 188
TABLE 69 ACQUISITIONS, 2011–2014 191
TABLE 70 APPROVALS, 2011–2014 193

LIST OF FIGURES

FIGURE 1 FORECAST MODEL 25
FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY 27
FIGURE 3 DATA TRIANGULATION 29
FIGURE 4 PORTER'S FIVE FORCES ANALYSIS 39
FIGURE 5 TECHNOLOGY LIFE CYCLE 44
FIGURE 6 DRIED BLOOD SPOT TEST INSTRUMENT MANUFACTURERS: STRATEGY 46
FIGURE 7 MARKET SEGMENTATION: NEWBORN SCREENING MARKET 57
FIGURE 8 MARKET DYNAMICS 59
FIGURE 9 MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2013 68
FIGURE 10 NEW BORN SCREENING BY TEST TYPE 79
FIGURE 11 GLOBAL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE,
2012–2019 ($MILLION) 80
FIGURE 12 NEW BORN SCREENING MARKET BY TECHNOLOGY 90
FIGURE 13 GLOBAL NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2013 106
FIGURE 14 NEWBORN SCREENING: TAPPED & UNTAPPED MARKETS 125
FIGURE 15 HIGH GROWTH POTENTIAL MARKET 126
FIGURE 16 KEY GROWTH STRATEGIES OF THE NEWBORN SCREENING MARKET, 2011–2014 179

Read the full report:
NewBorn Screening Market by Test Type, Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit – Global Forecast to 2019

https://www.reportbuyer.com/product/2238103/NewBorn-Screening-Market-by-Test-Type-Technology-Tandem-Mass-Spectrometry-Immunoassay-Enzyme-Assay-Electrophoresis-Pulse-Oximeter-Instrument-Accessories-Reagent--Assay-Kit-–-Global-Forecast-to-2019.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer